Publications by authors named "Julie Bose"

Claim this Profile
D
Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors.
Pradip K Gadekar, Ganesh Urunkar, Abhijit Roychowdhury, Rajiv Sharma, Julie Bose

Bioorg Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity.
Archana Jalota-Badhwar, Dimple R Bhatia, Srinivas Boreddy, Asavari Joshi, Magesh Venkatraman, Julie Bose

Mol Cancer Ther· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor.
Valmik Aware, Nitin Gaikwad, Sambhaji Chavan, Sonal Manohar, Julie Bose

Eur J Med Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer.
Venkatasubbaiah A Venkatesha, Asavari Joshi, Magesh Venkataraman, Vinay Sonawane, Dimple Bhatia, Julie Bose

Mol Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
Shivaji Kandre, Pundlik Rambhau Bhagat, M Mahesh Kumar Reddy, Roda Dalal, Amol Dixit, Julie Bose

Eur J Med Chem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of thiazolyl-phthalazinone acetamides as potent glucose uptake activators via high-throughput screening.
Madhavi Agrawal, Prashant Kharkar, Sonali Moghe, Tushar Mahajan, Vaishali Deka, Julie Bose

Bioorg Med Chem Lett· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel derivative of benzofuran induces cell death mostly by G2/M cell cycle arrest through p53-dependent pathway but partially by inhibition of NF-kappaB.
Sunil K Manna, Julie S Bose, Vijay Gangan, Nune Raviprakash, Thota Navaneetha

J Biol Chem· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dihydrobenzofuran lignan induces cell death by modulating mitochondrial pathway and G2/M cell cycle arrest.
Julie S Bose, Vijay Gangan, Ravi Prakash, Swatantra Kumar Jain, Sunil Kumar Manna

J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
Nilesh M Dagia, Divya V Kamath, Pooja Bhatt, Ravindra D Gupte, Shruta S Dadarkar, Julie Bose

Eur J Pharmacol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-KappaB: Potentiation of cell death mediated by chemotherapeutic agents.
Julie S Bose, Vijay Gangan, Swatantra K Jain, Sunil K Manna

J Cell Physiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of inflammatory responses by novel caffeic acid ester derivative by inhibiting NF-kappa B.
Julie S Bose, Vijay Gangan, Swatantra Kumar Jain, Sunil K Manna

J Clin Immunol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis